ストックスクリーナーアプリを入手
6.14
14.34%
0.77
アフターアワーズ：
6.12
-0.02
-0.33%
前日終値:
$5.37
開ける：
$5.52
24時間の取引高:
751.97K
Relative Volume:
2.20
時価総額：
$317.37M
収益：
-
当期純損益:
$-19.90M
株価収益率:
-11.58
EPS:
-0.53
ネットキャッシュフロー:
$-19.80M
1週間 パフォーマンス:
+7.53%
1か月 パフォーマンス:
+36.75%
6か月 パフォーマンス:
+0.99%
1年 パフォーマンス:
+59.48%
1日の値動き範囲:
$5.5014
$6.20
1週間の範囲:
$5.14
$6.20
52週間の値動き範囲:
$3.19
$6.8184
Diamedica Therapeutics Inc Stock (DMAC) Company Profile
名前
Diamedica Therapeutics Inc
セクター
電話
(763) 496-5454
住所
301 CARLSON PARKWAY, MINNEAPOLIS, MN
DMAC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DMAC
Diamedica Therapeutics Inc
|
6.14 | 277.57M | 0 | -19.90M | -19.80M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Diamedica Therapeutics Inc Stock (DMAC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-10-07 | 開始されました | H.C. Wainwright | Buy |
| 2024-04-24 | 再開されました | Craig Hallum | Buy |
| 2023-06-22 | アップグレード | Oppenheimer | Perform → Outperform |
| 2021-04-09 | 開始されました | Oppenheimer | Outperform |
| 2021-02-17 | 開始されました | ROTH Capital | Buy |
| 2020-10-30 | 開始されました | Guggenheim | Buy |
| 2020-07-08 | 開始されました | Maxim Group | Buy |
| 2019-04-30 | 開始されました | Dougherty & Company | Buy |
| 2019-03-05 | 開始されました | Lake Street | Buy |
すべてを表示
Diamedica Therapeutics Inc (DMAC) 最新ニュース
Full technical analysis of DiaMedica Therapeutics Inc. stock2025 Technical Overview & Free Fast Entry Momentum Trade Alerts - Newser
Ranking DiaMedica Therapeutics Inc. among high performing stocks via toolsWall Street Watch & Real-Time Chart Breakout Alerts - Newser
Is DiaMedica Therapeutics Inc. a candidate for recovery playWeekly Profit Report & Community Verified Trade Signals - Newser
Price momentum metrics for DiaMedica Therapeutics Inc. explainedMarket Growth Report & Risk Managed Trade Strategies - Newser
How institutional ownership impacts DiaMedica Therapeutics Inc. stockVolume Spike & Weekly High Momentum Picks - Newser
Is DiaMedica Therapeutics Inc. stock influenced by commodity pricesTrade Performance Summary & Daily Growth Stock Investment Tips - خودرو بانک
Does DiaMedica Therapeutics Inc. have declining or rising EPS2025 Earnings Impact & Safe Investment Capital Preservation Plans - خودرو بانک
Is DiaMedica Therapeutics Inc. forming higher highs and higher lows2025 Institutional Moves & Community Consensus Stock Picks - خودرو بانک
Published on: 2025-09-05 23:26:43 - خودرو بانک
Trend analysis for DiaMedica Therapeutics Inc. this weekWeekly Profit Summary & AI Driven Stock Price Forecasts - Newser
Combining price and volume data for DiaMedica Therapeutics Inc.2025 Big Picture & Low Risk Entry Point Tips - Newser
Can DiaMedica Therapeutics Inc. sustain its profitabilityGap Up & Weekly Sector Rotation Insights - خودرو بانک
DiaMedica Therapeutics Stock (DMAC) Opinions on Insider Buying and Conference Presentations - Quiver Quantitative
Diamedica Therapeutics shares rise 3.35% premarket after announcing participation in upcoming investor conferences. - AInvest
DiaMedica Therapeutics: Investor Conferences as Catalysts for Biotech Sector Re-Rating - AInvest
DiaMedica Therapeutics to Participate in Upcoming Investor Conferences - AInvest
Using AI based signals to follow DiaMedica Therapeutics Inc.2025 Technical Patterns & Low Drawdown Investment Ideas - Newser
Volatility clustering patterns for DiaMedica Therapeutics Inc.July 2025 Summary & Daily Stock Momentum Reports - Newser
Trill AB buys DiaMedica (DMAC) shares worth $5.96 million By Investing.com - Investing.com Canada
Trill AB buys DiaMedica (DMAC) shares worth $5.96 million - Investing.com
Applying Elliott Wave Theory to DiaMedica Therapeutics Inc.July 2025 Decliners & Weekly Market Pulse Updates - Newser
Using data filters to optimize entry into DiaMedica Therapeutics Inc.2025 Retail Activity & Target Return Focused Stock Picks - Newser
Is DiaMedica Therapeutics Inc. forming a bullish divergenceJuly 2025 Analyst Calls & Long Hold Capital Preservation Plans - خودرو بانک
Should you hold or exit DiaMedica Therapeutics Inc. now2025 Investor Takeaways & Safe Capital Growth Stock Tips - Newser
Understanding DiaMedica Therapeutics Inc.’s price movementRate Hike & Consistent Income Trade Ideas - Newser
How cyclical is DiaMedica Therapeutics Inc.’s revenue stream2025 Institutional Moves & Daily Market Momentum Tracking - خودرو بانک
Is DiaMedica Therapeutics Inc. stock a top performer YTD2025 Historical Comparison & High Return Stock Watch Alerts - خودرو بانک
Can DiaMedica Therapeutics Inc. hit a new high this monthRisk Management & High Conviction Trade Alerts - Newser
Published on: 2025-09-03 04:58:56 - Newser
Intraday pattern recognizer results for DiaMedica Therapeutics Inc.Quarterly Profit Report & Daily Profit Focused Screening - Newser
Is DiaMedica Therapeutics Inc. stock entering bullish territoryMarket Growth Summary & Reliable Breakout Stock Forecasts - Newser
Published on: 2025-09-03 08:43:38 - خودرو بانک
Applying Wyckoff theory to DiaMedica Therapeutics Inc. stockShare Buyback & Consistent Income Trade Recommendations - Newser
What to expect from DiaMedica Therapeutics Inc. in the next 30 daysPortfolio Growth Summary & Momentum Based Trading Signals - Newser
Can DiaMedica Therapeutics Inc. disrupt its industryTrade Exit Summary & Entry Point Confirmation Signals - خودرو بانک
Is DiaMedica Therapeutics Inc. stock forming a cup and handleJuly 2025 Weekly Recap & Free Weekly Watchlist of Top Performers - خودرو بانک
Applying chart zones and confluence areas to DiaMedica Therapeutics Inc.2025 Risk Factors & High Win Rate Trade Alerts - Newser
Diamedica Therapeutics shares fall 2.28% intraday after announcing participation in Cantor Global Healthcare Conference. - AInvest
DiaMedica Therapeutics to Participate in Cantor Global Healthcare Conference - Business Wire
Diamedica Therapeutics Inc (DMAC) 財務データ
収益
当期純利益
現金流量
EPS
1.40%
大文字化:
|
ボリューム (24 時間):